Germline PTEN mutations in Cowden syndrome-like families

Journal of Medical Genetics

Volumn 35, Issue 11, 1998, Pages 881-885

  Marsh, Debbie J ^a   Dahia, Patricia L M ^a   Caron, Stacey ^a   Kum, Jennifer B ^a   Frayling, Ian M ^b   Tomlinson, Ian P M ^c   Hughes, Kevin S ^d   Eeles, Rosalind A ^e   Hodgson, Shirley V ^e   Murday, Vicky A ^f   Houlston, Richard ^g   Eng, Charis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ST MARK S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Breast; Cowden syndrome; PTEN; Thyroid

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PHOSPHATASE; PROTEIN P53;

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BREAST CARCINOMA; CANCER GENETICS; CANCER INHIBITION; CANCER RISK; CHROMOSOME 10Q; COWDEN SYNDROME; DENATURING GRADIENT GEL ELECTROPHORESIS; EXON; FEMALE; FRAMESHIFT MUTATION; GEL ELECTROPHORESIS; GENE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 17344368045     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.11.881     Document Type: Article

References (14)

1. Starink TM, van der Veen JPW, Anvert F, et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986;29:222-33.
2. Eng C. Cowden syndrome. J Genet Counsel 1997;6:9181-92.
3. Malkin D, Li FP, Fraumeni JF Jr, et al. Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
4. Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 1990;348:747-9.
5. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
6. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
7. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
8. Easton DF, Bishop DT, Ford D, Crockford GP, Consortium BCL. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993;52:678-701.
9. Wooster R, Neuhausen SL, Manjion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-12. Science 1994;265:2088-90.
10. Eng C. From bench to bedside...but when? Genome Res 1997;7:669-72.
11. Varley JM, McGown G, Thorncroft M, et al. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 1997;57:3245-52.
12. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
13. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res 1997;57:2124-9.
14. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumor suppressor gene, MAIAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.